Dr. Reddy's Laboratories Flags Semaglutide Supply Delay, Says No Recall Risk
MarketBeat
byMarketBeat
Sunday, July 12, 2026 at 09:02 PM
Dr. Reddy's Laboratories (NYSE:RDY) said a scale-up issue tied to the active pharmaceutical ingredient for its semaglutide injection will temporarily delay c...
Key Points
<ul><li>Interested in Dr. Reddy's Laboratories Ltd? Here are five stocks we like better.
</li><li>Dr. Reddy's Laboratories said a scale-up issue involving the API for its semaglutide inj… [+6920 chars]
Language
eng
Source
MarketBeat
Category
general
Added
144d ago
